Stan Rockson

Piano-playing, French-speaking, tango-dancing, yoga-practicing cardiologist, passionate about biomedical research

[Stan Rockson @trasnochando]

I’m proud to announce my Principal Investigator role on a 5-year ARPA-H funded project: Drug/Device Combinations to Prevent Cancer-Associated Lymphedema @arpahealth @stanford @lymphaticnetwork

[Stan Rockson @trasnochando]

@IsaacLeeLab @CornellBME @mchvdm Congratulations, Isak

[Esak (Isaac) Lee @IsaacLeeLab]

NHLBI helps launch the first NIH National Commission on Lymphatic Diseases! https://t.co/FytSYDCTC2

[Catharine Bowman @CatharineBowman]

Pleased to see our latest paper, "The Role of Inflammation in Lymphedema: A Narrative Review of Pathogenesis and Opportunities for Therapeutic Intervention", published in the International Journal of Molecular Science. @trasnochando

https://t.co/grH9tPrmUO

[Circulation @CircAHA]

#OriginalResearch: Abnormal sphingosine-1-phosphate (S1P) signaling in lymphatic endothelial cells mediates pathogenic T cell activation, vascular insufficiency and lymphatic dysfunction @trasnochando @marknicolls https://t.co/u464hnW4uM

[Margaret Sneddon @MCSneddon1]

It was such a pleasure to have Prof Rockson @StanfordMed @LymphaticNet as keynote speaker at #BLS2023 conference - inspiring as always! @BritishLymph @trasnochando

[BLS @BritishLymph]

FINDING A DRUG FOR HUMAN LYMPHEDEMA: From Bedside to Bench to Bedside - a fantastic session from Professor Stanley Rockson.

Thank you to Stanley for travelling from the States to deliver such great sessions.

#BLS2023

[Stan Rockson @trasnochando]

@MCSneddon1 @StanfordMed @LymphaticNet @BritishLymph This was nut great honor - thank for the warm collegial welcome!

[Stan Rockson @trasnochando]

@IsaacLeeLab @CornellEng @CornellBME 🍾🍾🍾🍾🍾

[Stan Rockson @trasnochando]

@CMJThompson Désolé Madame, il fera de son mieux, mais il n’a que 3 ans

[Stan Rockson @trasnochando]

@lymphengineer so sorry I missed it and you

[Stan Rockson @trasnochando]

@Ballinaleegirl Everything is going well. We are seeing response to drug! - but we cannot perform any analysis until all trial events are completed. Like you, we are very hopeful....🙏🏻🙏🏻🙏🏻

[Stan Rockson @trasnochando]

Today, we enrolled the first subject in the HEAL trial (Human Upper Extremity Acebilustat Lymphedema Trial). The study is intended to further investigate the ability of the specific LTB4 antagonist to reverse the structural damage in human chronic #lymphedema.

[Stan Rockson @trasnochando]

@CastorenaLab @nih_nhlbi Yes, see you there!

[Stan Rockson @trasnochando]

@CastorenaLab @nih_nhlbi Congratulations, Jorge!

[Stan Rockson @trasnochando]

@ChadSWeldy @American_Heart @RNAedit @StanfordDeptMed @StanCVFellows Congratulations!🍾🍾🍾

[Stan Rockson @trasnochando]

@markkenney_3 @SchwarzLab_URMC @RocMSTP Congrats!

[Stan Rockson @trasnochando]

@lymphengineer Big props!!

[Stan Rockson @trasnochando]

Our paper - in collaboration with Professor Gianesini's laboratory and team - on the identification of the glycocalyx in the human #lymphatic vasculature is available on @ResearchGate: https://t.co/3vjggXtClf

[Stan Rockson @trasnochando]

@ShoaClarke Great points, Shoa! As a journal editor-in-chief, I can confirm the increasing unavailability of peer reviewers. I especially commend thr idea of recommending reviewers who are valid and likely to be receptive.

[Stan Rockson @trasnochando]

@IsaacLeeLab Congrats Esak